Literature DB >> 2126034

Impact of surfactant treatment on cost of neonatal intensive care: a cost-benefit analysis.

T A Merritt1, M Hallman, Y Vaucher, E McFeeley, T R Tubman.   

Abstract

Mesh:

Substances:

Year:  1990        PMID: 2126034

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


× No keyword cloud information.
  6 in total

Review 1.  Drug utilisation in preterm and term neonates.

Authors:  L Gortner
Journal:  Pharmacoeconomics       Date:  1993-12       Impact factor: 4.981

2.  Economic outcomes of colfosceril palmitate rescue therapy in infants weighing 1250g or more with respiratory distress syndrome: results from a randomised trial.

Authors:  M E Backhouse; J A Mauskopf; D Jones; D E Wold; R Schumacher; R Cotton; W A Long
Journal:  Pharmacoeconomics       Date:  1994-10       Impact factor: 4.981

3.  The cost of neonatal care: reviewing the evidence.

Authors:  M Mugford
Journal:  Soz Praventivmed       Date:  1995

Review 4.  Paediatrics--Part I.

Authors:  B L Priestley; C J Harrison; M P Gerrard; A Gibson
Journal:  Postgrad Med J       Date:  1993-03       Impact factor: 2.401

5.  A pharmacoeconomic analysis of in-hospital costs resulting from reintubation in preterm infants treated with lucinactant, beractant, or poractant alfa.

Authors:  Carlos G Guardia; Fernando R Moya; Sunil Sinha; Phillip D Simmons; Robert Segal; Jay S Greenspan
Journal:  J Pediatr Pharmacol Ther       Date:  2012-07

Review 6.  Neonatal technology, perinatal survival, social consequences, and the perinatal paradox.

Authors:  R M Kliegman
Journal:  Am J Public Health       Date:  1995-07       Impact factor: 9.308

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.